Because of Ezra   Report issue

Foundation Phase 1 Phase 2
Founded: Tampa FL United States (2012)

Organization Overview

First Clinical Trial
2014
NCT02139397
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuroblastoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 7